FRONTIER BIOTECHNOLOGIES Inc.

News

FRONTIER BIOTECHNOLOGIES Inc
Home>News>Frontier Biotech Announced the Appointment of Dr. Huyi Zhang and Mr. Jie Deng to its Senior Management Team

Frontier Biotech Announced the Appointment of Dr. Huyi Zhang and Mr. Jie Deng to its Senior Management Team

  • 2018-03-05  10:59:09

March 5th, 2018  Nanjing

Dr. Huyi (John) Zhang, was appointed as Vice President of Regulatory Affairs. Dr. Zhang is an expert in drug registration and regulatory science with rich experience in drug discovery and development. Prior to joining Frontier Biotech, he was Head of Regulatory Affairs at Simcere. Prior to that, Dr. Zhang worked at US FDA with a track record of increasing responsibilities as a reviewer, supervisor and associate director. He was at Wyeth (acquired by Pfizer) as senior scientist and project leader. Dr. Zhang is also an instructor for CFDA Institute of Executive Development and CDE, and a member of ICH Quality Guidance Expert Team at CDE. Dr. Zhang earned his PhD degree from Peking University School of Pharmaceutical Science and had post-doc training at Worcester Polytechnic Institute in the US.

Mr. Jie Deng was appointed as Vice President of Manufacturing. Mr. Deng has over 30 years’ experience in chemical drug R&D, manufacturing, exporting, GMP certificating and facility building. Prior to joining Frontier Biotech, Mr. Deng was Vice President of Fosun Pharma Research Institute, President and Chief Engineer of Chongqing Pharmaceutical Research Institute. Mr. Deng was a graduate of College of Pharmacy Huaxi Medical University and CEIBS.

Dr. CJ Wang, CEO of Frontier Biotech, said, “We sincerely welcome John and Jie joining Frontier Biotech at the exciting time of transiting from an R&D organization to fully integrated biopharma company. They both have expertise and rich experiences in their fields. Hope together we’ll grow Frontier Biotech to become a top-notch biopharmaceutical company with global competitiveness.”


Innovative solutions to promote human health